Pharmacology Research Institute
M3 Wake Research (Pharmacology Research Institute) is a wholly owned M3 subsidiary operating an integrated North American network of clinical trial sites that recruit participants and conduct studies across 14 therapeutic areas for pharmaceutical, biotechnology, medical device, and CRO sponsors.
- Company typePrivate
- Founded1994
- HeadquartersLos Alamitos, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Pharmacology Research Institute does
M3 Wake Research, operating under the legal name Pharmacology Research Institute, is a wholly owned subsidiary of M3 and operates an integrated network of premier investigational clinical trial sites across North America. The organization conducts clinical research studies evaluating the efficacy and safety of new investigational medications, therapies, medical devices, and disease management approaches for pharmaceutical, biotechnology, medical device, and clinical research organization (CRO) sponsors. Its study portfolio spans 14 therapeutic areas including Alzheimer's, autoimmune disorders, cardiology, dermatology, gastroenterology, hepatology/nephrology, neurology/behavioral health, obesity, oncology/hematology, orthopedics, pulmonology, diabetes, vaccines/prevention, and women's health.
The business is built around three operational pillars: participant recruitment (via a self-service website clinical trial finder, a community physician referral network, and an email-based participant referral program), trial conduct at equipped investigational sites with advanced diagnostic equipment, and standardized data collection and reporting to sponsors while preserving participant privacy. The company reports 674 studies completed and 19,000+ participants enrolled over the past five years, alongside 30+ years of clinical research experience. There is no public disclosure of revenue, funding rounds, leadership personnel, patents, or AI/ML capabilities in the source data.
Revenue mechanics follow a professional services model: sponsors and CROs pay for clinical trial conduct services, while participation is free for individual volunteers who may receive compensation for time and travel. Go-to-market combines B2B direct enterprise sales to pharmaceutical, biotech, medical device, and CRO buyers with B2C direct-to-consumer recruitment. The company is privately held under M3, a strategic operating parent, with operations based in Los Alamitos, California and a workforce of 51–100 employees.
Pharmacology Research Institute firmographics
Firmographics- Name
- Pharmacology Research Institute
- Legal name
- M3 Wake Research
- Website
- https://priresearch.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- M3 Wake Research (Pharmacology Research Institute) is a wholly owned M3 subsidiary operating an integrated North American network of clinical trial sites that recruit participants and conduct studies across 14 therapeutic areas for pharmaceutical, biotechnology, medical device, and CRO sponsors.
- Ownership category
- akta.pro rank
Pharmacology Research Institute industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Pharmacology Research Institute is headquartered
LocationHeadquarters
- HQ city
- Los Alamitos
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Pharmacology Research Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Services: Revenue generated by conducting clinical trials for pharmaceutical sponsors, biotechnology companies, medical device companies, and clinical research organizations. Services include participant recruitment, trial conduct, and data collection/analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Free participation for clinical trial volunteers with potential compensation |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Pharmacology Research Institute product offering
Product offeringCore offering
Pharmacology Research Institute, operating as M3 Wake Research, conducts clinical research trials for biopharmaceutical, biotechnology, medical device, and pharmaceutical industry clients, as well as CROs. Services encompass participant recruitment, protocol-driven trial conduct at wholly owned investigational sites across North America, and collection/verification of medical data and results reporting. The company also recruits and enrolls individual volunteers through its website and community physician partnerships.
Product overview
M3 Wake Research is a unified clinical research platform offering integrated investigational site services to the biopharmaceutical, biotechnology, medical device, and pharmaceutical industries. The organization operates premier investigational sites across North America, providing a comprehensive portfolio of therapeutic area clinical studies including Alzheimer's, autoimmune disorders, cardiology, dermatology, gastroenterology, hepatology/nephrology, neurology/behavioral health, obesity, oncology/hematology, orthopedics, pulmonology, diabetes, vaccines/prevention, and women's health. Their core service encompasses participant recruitment, trial conduct, and results analysis, with a track record of 19K+ participants and 674 studies completed over 30+ years.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Trial Services Core clinical research trial services for pharmaceutical, biotechnology, medical device, and CRO clients, evaluating the efficacy and safety of new investigational treatments, therapies, medical devices, and disease management approaches across a network of wholly owned investigational sites in North America.
Quantifiable outcome
- 19K+ participants enrolled in clinical studies over five years
- +2 more outcomes
Companies that use Pharmacology Research Institute
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Pharmacology Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Pharmacology Research Institute partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Community PhysicianscorePartnership with community physicians for patient referrals to clinical trials. Physicians refer eligible patients while M3 Wake Research provides trial infrastructure and care.
- Biopharmaceutical CompaniescoreCollaborative relationships with pharmaceutical companies to conduct clinical trials for new investigational medications, providing participant recruitment, trial conduct, and data collection services.
- Clinical Research Organizations (CROs)coreSite network partnership with CROs for conducting multi-location clinical trials, providing standardized protocol execution and data collection across investigational sites.
- Medical Device CompaniescorePartnership with medical device companies to evaluate safety and efficacy of medical devices through clinical trials at equipped facilities.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Pharmacology Research Institute competitors and assessment
Company assessmentBroad incumbents
- Medpace: Mid-to-large global CRO with strong site network partnerships and full-service clinical development. Competes for the same biopharma/biotech study awards as Wake Research.
- IQVIA: Largest global CRO that also operates site management services alongside full-service clinical trial delivery. Comparable end-customer base (biopharma/biotech sponsors) and overlapping SMO capability, but as part of a much broader portfolio.
- ICON plc: Large global CRO with dedicated site solutions (e.g., PRA Health, Symphony Clinical Research). Overlaps with Wake Research on site-based trial conduct and same biopharma sponsor customer base.
- Syneos Health: Biopharmaceutical services organization offering both CRO and site management capabilities, serving the same pharmaceutical/biotech sponsor base as Wake Research.
Direct peers
- Flourish Research: Multi-therapeutic-area integrated site network focused on Phase II–IV clinical trials for pharma and biotech sponsors. Comparable owned-site, multi-TA SMO operating model to Wake Research.
- Velocity Clinical Research: Integrated, wholly-owned multi-site clinical research organization in the U.S. operating a large network of investigational sites across multiple therapeutic areas — directly comparable business model and service offering to M3 Wake Research.
- Accelerated Enrollment Solutions (PPD/Thermo Fisher): Dedicated SMO subsidiary of a large CRO, operating a network of owned patient enrollment centers across the U.S. — same SMO business model as Wake Research but with parent CRO distribution leverage.
- Clinilabs: Clinical research site organization with multiple owned U.S. sites specializing in CNS, psychiatry, and other therapeutic areas — comparable site-based trial delivery to Wake Research.
- Altasciences (formerly WCCT Global): Multi-site early-phase clinical research organization offering site-based trial conduct across therapeutic areas. Closely comparable owned-site, multi-TA service model.
Emerging players
- Benchworks (Benchmark Research): Smaller multi-therapeutic-area site research organization providing Phase II–IV clinical trial conduct — partial overlap with Wake Research on owned-site trial delivery at sub-scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Pharmacology Research Institute social profiles
Digital presencePharmacology Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmacology Research Institute leadership team
Management profileNumber of profiles
Pharmacology Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmacology Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmacology Research Institute
What does Pharmacology Research Institute do?
Pharmacology Research Institute, operating as M3 Wake Research, conducts clinical research trials for biopharmaceutical, biotechnology, medical device, and pharmaceutical industry clients, as well as CROs. Services encompass participant recruitment, protocol-driven trial conduct at wholly owned investigational sites across North America, and collection/verification of medical data and results reporting. The company also recruits and enrolls individual volunteers through its website and community physician partnerships.
Is Pharmacology Research Institute a public or private company?
Pharmacology Research Institute is a private company. It is classified as corporate owned and is currently operating.
When was Pharmacology Research Institute founded?
Pharmacology Research Institute was founded in 1994. It employs 51 to 100 people.
Where is Pharmacology Research Institute based?
Pharmacology Research Institute is headquartered in Los Alamitos, United States, in the North America region.
How does Pharmacology Research Institute make money?
One revenue line is on record: clinical Trial Services.
Who are Pharmacology Research Institute's main competitors?
Broad incumbents on record are Medpace, IQVIA, ICON plc and Syneos Health. Direct peers are Flourish Research, Velocity Clinical Research, Accelerated Enrollment Solutions (PPD/Thermo Fisher), Clinilabs and Altasciences (formerly WCCT Global). Benchworks (Benchmark Research) is listed as an emerging player.
Does Pharmacology Research Institute have an API?
No public API is recorded for Pharmacology Research Institute.
What industry is Pharmacology Research Institute in?
Pharmacology Research Institute's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 54171 and its SIC code is 8731.